{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:14Z","timestamp":1793672954509,"version":"4.5.1"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04326\/2020"],"award-info":[{"award-number":["UIDB\/04326\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nano.2025.102854","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:10:20Z","timestamp":1756480220000},"page":"102854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nanomedicine in oncology: Diagnostic breakthroughs and therapeutic Frontiers"],"prefix":"10.1016","volume":"69","author":[{"given":"Adeeb","family":"Shehzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazhar","family":"Ul-Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Khamis Al Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia O.D.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sherjeel Javed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Fonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nano.2025.102854_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.nano.2025.102854_bb0010","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nano.2025.102854_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","article-title":"Priorities for cancer research in low- and middle-income countries: a global perspective","volume":"28","author":"Pramesh","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2025.102854_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124340","article-title":"Camptothecin-loaded mesoporous silica nanoparticles functionalized with CpG oligodeoxynucleotide as a new approach for skin cancer treatment","volume":"660","author":"Qureshi","year":"2024","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2025.102854_bb0025","first-page":"187","article-title":"Green synthesized silver nanoparticles using Rhazya stricta extract for delivery of HDAC inhibitor panobinostat in MDA-MB-231 breast cancer cell line","volume":"11","author":"Nawaz","year":"2023","journal-title":"Nanomed J"},{"key":"10.1016\/j.nano.2025.102854_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.nano.2025.102854_bb0035","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1039\/C6CS00592F","article-title":"Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment","volume":"46","author":"Dai","year":"2017","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2025.102854_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2025.102854_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00204-020-02940-x","article-title":"Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models","volume":"95","author":"Vilas-Boas","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nano.2025.102854_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41565-020-00817-9","article-title":"Considerations for designing preclinical cancer immune nanomedicine studies","volume":"16","author":"Jiang","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0055","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/acsami.5b11619","article-title":"An MMP-2 responsive liposome integrating antifibrosis and chemotherapeutic drugs for enhanced drug perfusion and efficacy in pancreatic cancer","volume":"8","author":"Ji","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102854_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107806","article-title":"Extracellular vesicles in cancer diagnostics and therapeutics","volume":"223","author":"Shehzad","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.nano.2025.102854_bb0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2217\/nnm-2019-0429","article-title":"Quantum dots encapsulated with curcumin inhibit the growth of colon cancer, breast cancer, and bacterial cells","volume":"15","author":"Alam","year":"2020","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.nano.2025.102854_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma","volume":"3","author":"Kim","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.nano.2025.102854_bb0075","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2016.5989","article-title":"Screening for colorectal cancer: US preventive services task force recommendation statement","volume":"315","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.nano.2025.102854_bb0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1053\/j.gastro.2017.11.025","article-title":"Computed tomography colonography vs colonoscopy for colorectal cancer surveillance after surgery","volume":"154","author":"Weinberg","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2025.102854_bb0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","article-title":"Effect of colonoscopy screening on risks of colorectal cancer and related death","volume":"387","author":"Bretthauer","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2025.102854_bb0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41565-019-0527-6","article-title":"Renal clearable catalytic gold nanoclusters for in vivo disease monitoring","volume":"14","author":"Loynachan","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acsnano.5b06007","article-title":"Ultrasensitive, multiplex Raman frequency shift immunoassay of liver cancer biomarkers in physiological media","volume":"10","author":"Tang","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5583","article-title":"Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers","volume":"9","author":"Kim","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2025.102854_bb0105","doi-asserted-by":"crossref","first-page":"25878","DOI":"10.1021\/acsami.7b07384","article-title":"Carbon nanotube matrix for highly sensitive biosensors to detect pancreatic cancer biomarker CA19-9","volume":"9","author":"Thapa","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102854_bb0110","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1016\/j.biomaterials.2011.03.077","article-title":"Gadolinium-loaded polymeric nanoparticles modified with anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer","volume":"32","author":"Liu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700912","article-title":"Dendron-grafted polylysine-based dual-modal nanoprobe for ultraearly diagnosis of pancreatic precancerosis via targeting a urokinase-type plasminogen activator receptor","volume":"7","author":"Li","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2025.102854_bb0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/acs.nanolett.8b04179","article-title":"Magnetic semiconductor Gd-doping CuS nanoparticles as activatable nanoprobes for bimodal imaging and targeted photothermal therapy of gastric tumors","volume":"19","author":"Shi","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2025.102854_bb0125","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6086","article-title":"Synthesis, characterization, and antibacterial activity of silver nanoparticles using Rhazya stricta","volume":"6","author":"Shehzad","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.nano.2025.102854_bb0130","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1021\/acsnano.8b01573","article-title":"Epidermal growth factor receptor-targeting peptide nanoparticles simultaneously deliver gemcitabine and olaparib to treat pancreatic cancer with BRCA2 mutation","volume":"12","author":"Du","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0135","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acsnano.0c10276","article-title":"Tumor-selective immune-active mild hyperthermia associated with chemotherapy in colon peritoneal metastasis by photoactivation of fluorouracil-gold nanoparticle complexes","volume":"15","author":"Mulens-Arias","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118810","article-title":"Hydrazided hyaluronan\/cisplatin\/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer","volume":"276","author":"Hou","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2025.102854_bb0145","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.2174\/1381612825666191009161018","article-title":"Switching from conventional to nano-natural phytochemicals to prevent and treat cancers: special emphasis on resveratrol","volume":"25","author":"Islam","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2025.102854_bb0150","article-title":"Ferritin nanocaged doxorubicin potentiates chemoimmunotherapy against hepatocellular carcinoma via immunogenic cell death","volume":"7","author":"Chen","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.nano.2025.102854_bb0155","first-page":"1292","article-title":"Spatial, temporal, and dose control of drug delivery using noninvasive magnetic stimulation","volume":"13","author":"Chen","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.09.014","article-title":"Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: in vitro and in vivo evaluation","volume":"266","author":"Cervello","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102854_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201701070","article-title":"Sequentially triggered nanoparticles with tumor penetration and intelligent drug release for pancreatic cancer therapy","volume":"5","author":"He","year":"2018","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2025.102854_bb0170","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.2147\/IJN.S340180","article-title":"In vitro and in vivo evaluation of a novel estrogen-targeted PEGylated oxaliplatin liposome for gastric cancer","volume":"16","author":"Sun","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102854_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202370287","article-title":"Butyrate modification promotes intestinal absorption and hepatic cancer cell targeting of ferroptosis inducer loaded nanoparticle for enhanced hepatocellular carcinoma therapy","volume":"19","author":"Yu","year":"2023","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.nano.2025.102854_bb0180","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/17425247.2022.2135502","article-title":"Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications","volume":"19","author":"Lopes","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2025.102854_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2025.102854_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114357","article-title":"Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment","volume":"187","author":"Tarannum","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102854_bb0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/acsnano.8b06164","article-title":"Improved efficacy and reduced toxicity using a custom-designed irinotecan-delivering silicasome for orthotopic colon cancer","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0200","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1021\/nn100918a","article-title":"In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy","volume":"4","author":"Li","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0205","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2025.102854_bb0210","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1021\/acs.nanolett.9b00374","article-title":"Codelivery nanosystem targeting the deep microenvironment of pancreatic cancer","volume":"19","author":"Chen","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2025.102854_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.09.014","article-title":"Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system","volume":"241","author":"Chen","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102854_bb0220","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2147\/IJN.S198747","article-title":"Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy","volume":"14","author":"Zhang","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102854_bb0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41565-017-0012-z","article-title":"Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression","volume":"13","author":"Pi","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0230","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41596-022-00698-3","article-title":"Formulation of two lipid-based membrane\u2013core nanoparticles for FOLFOX combination therapy","volume":"17","author":"Guo","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nano.2025.102854_bb0235","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.biomaterials.2011.11.024","article-title":"Suppression of tumor growth in H-ras12V liver cancer mice by delivery of programmed cell death protein 4 using galactosylated poly(ethylene glycol)-chitosan-graft-spermine","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0240","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.biomaterials.2011.11.082","article-title":"An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.nano.2025.102854_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10893-8","article-title":"Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy","volume":"10","author":"Hu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15130","article-title":"Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer","volume":"8","author":"Lei","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0260","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1158\/0008-5472.CAN-17-2268","article-title":"IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment","volume":"78","author":"Karakasheva","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2025.102854_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118423","article-title":"Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression","volume":"260","author":"Salimifard","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2025.102854_bb0270","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2017.01.004","article-title":"Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment","volume":"31","author":"Katlinski","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nano.2025.102854_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/283649","article-title":"Activation of dendritic cells by the novel toll-like receptor 3 agonist RGC100","volume":"2013","author":"Naumann","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.nano.2025.102854_bb0280","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2019.09.021","article-title":"Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy","volume":"313","author":"Wei","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102854_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aaw6071","article-title":"A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer","volume":"6","author":"Ni","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2025.102854_bb0290","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1038\/s41467-020-17637-z","article-title":"A nanoscale metal-organic frameworks-based vaccine synergizes with PD-1 blockade to potentiate anti-tumor immunity","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903462","article-title":"Boosting interleukin-12 antitumor activity and synergism with immunotherapy by targeted delivery with isoDGR-tagged nanogold","volume":"15","author":"Gasparri","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.nano.2025.102854_bb0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-017-02251-3","article-title":"Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0305","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1021\/acsnano.0c03109","article-title":"Cancer cell coating nanoparticles for optimal tumor-specific cytokine delivery","volume":"14","author":"Barberio","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0310","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.biomaterials.2012.02.014","article-title":"Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP nanoparticles formulated with IL-12","volume":"33","author":"Xu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14179","article-title":"Polymeric mechanical amplifiers of immune cytokine mediated apoptosis","volume":"8","author":"Mitchell","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0320","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2015.04.003","article-title":"Paracrine co-delivery of TGF-\u03b2 and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells","volume":"59","author":"McHugh","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700012","article-title":"Dendritic mesoporous silica nanoparticles for pH-stimuli-responsive drug delivery of TNF-alpha","volume":"6","author":"Kienzle","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2025.102854_bb0330","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.7150\/thno.24157","article-title":"Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2025.102854_bb0335","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1021\/acsnano.9b02875","article-title":"Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0340","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.vaccine.2017.03.067","article-title":"Investigation of phosphorylated adjuvants coencapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis","volume":"35","author":"Goodwin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2025.102854_bb0345","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2017.10.050","article-title":"Nanoliposome C6-ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice","volume":"154","author":"Li","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2025.102854_bb0350","article-title":"Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis","volume":"10","author":"Yu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0355","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2020.02.011","article-title":"Remodeling tumor immune microenvironment via targeted blockade of PI3K-gamma and CSF-1\/CSF-1R pathways in tumor-associated macrophages for pancreatic cancer therapy","volume":"321","author":"Li","year":"2020","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.nano.2025.102854_bb0360","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4155\/tde.14.82","article-title":"How to overcome the limitations of current insulin administration with new non-invasive delivery systems","volume":"6","author":"Sousa","year":"2015","journal-title":"Ther Deliv"},{"issue":"17","key":"10.1016\/j.nano.2025.102854_bb0365","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2217\/nnm-2016-0045","article-title":"Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery","volume":"11","author":"Andrade","year":"2016","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.nano.2025.102854_bb0370","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2015.03.050","article-title":"Solid state formulations composed by amphiphilic polymers for delivery of proteins: characterization and stability","volume":"486","author":"Andrade","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102854_bb0375","doi-asserted-by":"crossref","first-page":"22613","DOI":"10.1021\/acsami.0c04533","article-title":"Multifunctional siRNA-laden hybrid nanoplatform for noninvasive PA\/IR dual-modal imaging-guided enhanced photogenetherapy","volume":"12","author":"Feng","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102854_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119760","article-title":"Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy","volume":"234","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0385","doi-asserted-by":"crossref","first-page":"47330","DOI":"10.1021\/acsami.0c15419","article-title":"Leukocyte-mediated combined targeted chemo and gene therapy for esophageal cancer","volume":"12","author":"Jun","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102854_bb0390","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41565-022-01266-2","article-title":"Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy","volume":"18","author":"Chen","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903332","article-title":"Supramolecular prodrug nanovectors for active tumor targeting and combination immunotherapy of colorectal cancer","volume":"7","author":"Hu","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2025.102854_bb0400","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41565-019-0589-5","article-title":"Nanotechnology intervention of the microbiome for cancer therapy","volume":"14","author":"Song","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805007","article-title":"Trapping of lipopolysaccharide to promote immunotherapy against colorectal cancer and attenuate liver metastasis","volume":"30","author":"Song","year":"2018","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.nano.2025.102854_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/gidisord7010007","article-title":"Microbiome-driven therapeutics: from gut health to precision medicine","volume":"7","author":"Yaqub","year":"2025","journal-title":"Gastrointestinal Disorders"},{"issue":"1","key":"10.1016\/j.nano.2025.102854_bb0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy","volume":"9","author":"Cao","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.nano.2025.102854_bb0420","article-title":"Tumor microbiome metabolism: a game changer in cancer development and therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2025.102854_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax5032","article-title":"Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer","volume":"6","author":"Huang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2025.102854_bb0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.06.009","article-title":"Cancer phototherapy with nano-bacteria biohybrids","volume":"360","author":"Lu","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102854_bb0435","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12951-022-01613-4","article-title":"Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer","volume":"20","author":"Deng","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0440","article-title":"Tumor-microenvironment-activatable polymer nanoimmunomodulator for precision cancer photoimmunotherapy","volume":"34","author":"Liu","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2025.102854_bb0445","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2023.03.042","article-title":"Metal coordination micelles for anti-cancer treatment by gene-editing and phototherapy","volume":"357","author":"Zhang","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102854_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300878","article-title":"Nano ultrasound contrast agent for synergistic chemophotothermal therapy and enhanced immunotherapy against liver cancer and metastasis","volume":"10","author":"Qiu","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2025.102854_bb0455","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.7150\/ijbs.58773","article-title":"Application of phototherapeutic-based nanoparticles in colorectal cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.nano.2025.102854_bb0460","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2018.04.030","article-title":"Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy","volume":"282","author":"Gao","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102854_bb0465","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.ymthe.2021.05.017","article-title":"Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles","volume":"29","author":"Yuan","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2025.102854_bb0470","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actbio.2022.03.023","article-title":"Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer","volume":"144","author":"Liu","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2025.102854_bb0475","doi-asserted-by":"crossref","first-page":"16553","DOI":"10.1021\/acsnano.3c02148","article-title":"The dual-response-single-amplification fluorescent nanomachine for tumor imaging and gastric cancer diagnosis","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0480","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.2147\/IJN.S137245","article-title":"Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer","volume":"12","author":"Luo","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102854_bb0485","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biomaterials.2018.07.060","article-title":"Dual drug delivery and sequential release by amphiphilic Janus nanoparticles for liver cancer theranostics","volume":"181","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102854_bb0490","doi-asserted-by":"crossref","first-page":"29232","DOI":"10.1021\/acsami.6b06883","article-title":"Cancer diagnosis and imaging-guided photothermal therapy using a dual-modality nanoparticle","volume":"8","author":"Zeng","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102854_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300878","article-title":"Nano ultrasound contrast agent for synergistic chemophotothermal therapy and enhanced immunotherapy against liver cancer and metastasis","volume":"10","author":"Qiu","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2025.102854_bb0500","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41392-024-01859-4","article-title":"Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2025.102854_bb0505","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1021\/acsabm.4c00074","article-title":"T cell and natural killer cell membrane-camouflaged nanoparticles for cancer and viral therapies","volume":"7","author":"Ozsoy","year":"2024","journal-title":"ACS Applied Bio Materials"},{"key":"10.1016\/j.nano.2025.102854_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.215712","article-title":"At the crossroad of nanotechnology and cancer cell membrane coating: expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting","volume":"506","author":"Pan","year":"2024","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.nano.2025.102854_bb0515","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/nano14050413","article-title":"Engineered cell membrane-camouflaged nanomaterials for biomedical applications","volume":"14","author":"Guan","year":"2024","journal-title":"Nanomaterials"},{"issue":"2025","key":"10.1016\/j.nano.2025.102854_bb0520","article-title":"Cell membrane-camouflaged nanoparticles: a promising biomimetic platform for tumor therapy","volume":"58","author":"Lyu","year":"2025","journal-title":"J Chem Eng Jpn"},{"key":"10.1016\/j.nano.2025.102854_bb0525","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.nano.2025.102854_bb0530","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nature Reviews Materials"},{"key":"10.1016\/j.nano.2025.102854_bb0535","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2025.102854_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188779","article-title":"Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment","volume":"1877","author":"Sia","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.nano.2025.102854_bb0545","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.drudis.2017.01.016","article-title":"Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?","volume":"22","author":"Musazzi","year":"2017","journal-title":"Drug Discov Today"},{"issue":"7","key":"10.1016\/j.nano.2025.102854_bb0550","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1021\/acsnano.2c00128","article-title":"Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology","volume":"16","author":"Domingues","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102854_bb0555","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102854_bb0560","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nano.2025.102854_bb0565","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00204-020-02940-x","article-title":"Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models","volume":"95","author":"Vilas-Boas","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nano.2025.102854_bb0570","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41565-020-00817-9","article-title":"Considerations for designing preclinical cancer immune nanomedicine studies","volume":"16","author":"Jiang","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2025.102854_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102854_bb0580","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102854_bb0585","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41541-024-00932-x","article-title":"Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza","volume":"9","author":"Cui","year":"2024","journal-title":"npj Vaccines"},{"issue":"1410","key":"10.1016\/j.nano.2025.102854_bb0590","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat Commun"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:20:20Z","timestamp":1778818820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":118,"alternative-id":["S1549963425000553"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102854","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine in oncology: Diagnostic breakthroughs and therapeutic Frontiers","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102854"}}